B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CTBP1

MOLECULAR TARGET

C-terminal binding protein 1

UniProt: Q13363NCBI Gene: 14875 compounds

CTBP1 (C-terminal binding protein 1) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CTBP1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1NAD2.087
2NAD2.087
3NAD2.087
4Carmine Coloring matter from0.691
5Diiodotyrosine0.691

About CTBP1 as a Drug Target

CTBP1 (C-terminal binding protein 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented CTBP1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CTBP1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.